CURE’s gastric cancer page is a go-to resource for oncology news and updates in the world of gastric cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in gastric cancer.
May 3rd 2024
For certain patients with HER2-positive gastric cancers, a Keytruda treatment combination has shown promising survival outcomes.
Enhertu Receives FDA Approval for Gastroesophageal, Gastric Cancer Subset
January 15th 2021The Food and Drug Administration approved Enhertu to treat adults with locally advanced or metastatic HER2-positive gastroesophageal or gastric cancer who have previously received a trastuzumab-based treatment regimen.
Eradicating Infection to Reduce Gastric Cancer Risk
February 7th 2020Study findings showed that eradicating Helicobacter pylori infection reduced the risk of developing gastric cancer by 73% in those with a first-degree relative with the disease, compared with individuals in whom infection was persistent.
BRAF V600E-Mutated Cholangiocarcinoma Responds to Drug Combo
March 15th 2019Nearly half of patients with a particular type of cholangiocarcinoma responded to a combination of two targeted drugs — Tafinlar (dabrafenib) and Mekinist (trametinib), which together inhibit the growth-signaling proteins BRAF and MEK in patients with different types of rare cancers that carry the BRAF V600E gene mutation.
FDA Grants Priority Review to Lonsurf for Gastric Adenocarcinoma
October 26th 2018The Food and Drug Administration (FDA) has granted a priority review to a supplemental new drug application for Lonsurf (TAS-102; trifluridine/tipiracil) for use in previously treated patients with advanced or metastatic gastric adenocarcinoma, including cancer of the gastroesophageal junction.